[1]
Ruiz, R. et al. 2024. Nimotuzumab and CIMAvax-EGF® in Advanced Cervical Cancer. BioNatura Journal: Ibero-American Journal of Biotechnology and Life Sciences. 1, 4 (Dec. 2024), 13. DOI:https://doi.org/10.70099/BJ/2024.01.04.20.